Tortoise Investment Management LLC lowered its position in Myokardia Inc (NASDAQ:MYOK) by 33.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,265 shares of the biotechnology company’s stock after selling 1,133 shares during the quarter. Tortoise Investment Management LLC’s holdings in Myokardia were worth $112,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in the stock. MetLife Investment Advisors LLC purchased a new stake in Myokardia during the fourth quarter worth $384,000. Hershey Trust Co. purchased a new stake in Myokardia during the first quarter worth $941,000. Alps Advisors Inc. lifted its holdings in Myokardia by 21.0% during the first quarter. Alps Advisors Inc. now owns 47,936 shares of the biotechnology company’s stock worth $2,339,000 after buying an additional 8,332 shares during the period. DekaBank Deutsche Girozentrale purchased a new stake in Myokardia during the first quarter worth $620,000. Finally, Fernwood Investment Management LLC lifted its holdings in Myokardia by 5.8% during the first quarter. Fernwood Investment Management LLC now owns 279,673 shares of the biotechnology company’s stock worth $13,648,000 after buying an additional 15,219 shares during the period. 77.17% of the stock is currently owned by institutional investors.
Hot Biotech Stocks To Buy Right Now: Alnylam Pharmaceuticals Inc.(ALNY)
Advisors' Opinion:- [By Max Byerly]
Get a free copy of the Zacks research report on Alnylam Pharmaceuticals (ALNY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Logan Wallace]
Alnylam Pharmaceuticals (NASDAQ:ALNY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Although Alnylam has a broad and promising pipeline, we note that most candidates are in mid stages of development. These candidates still have a long way to go before hitting the market. The company relies highly on collaborators for funding. Any development/regulatory setback would be a negative for the company. However, Alnylam reported positive data from the ATLAS study in the first quarter which led to regulatory filings for its late-stage pipeline candidate patisiran and the FDA set an action date of Aug 11, 2018. The company along with its partners Sanofi and The Medicines Company, restarted fitusiran's ATLAS phase III study and advanced inclisiran in the ORION-9, -10, and -11 phase III studies, respectively, with results expected for both programs in 2019. Alnylam expects to achieve the profile of three marketed products by the end of 2020.”
- [By Sean Williams, Chuck Saletta, and Brian Feroldi]
So, which biotech stocks should you consider buying in June? That's a question we posed to three of our healthcare-focused investors. Interestingly enough, mid-cap biotech stocks are the clear flavor of the month. If biotech is on your radar in June, our investors suggest you consider Ionis Pharmaceuticals (NASDAQ:IONS), Spark Therapeutics (NASDAQ:ONCE), and Alnylam Pharmaceuticals (NASDAQ:ALNY).
- [By Brian Orelli]
Shares of Alnylam Pharmaceuticals (NASDAQ:ALNY) were up 19% at 12:04 p.m. EDT on Monday after rival Pfizer (NYSE:PFE) released data for its transthyretin amyloid (ATTR) drug tafamidis at the ESC Congress 2018, which were also published in the New England Journal of Medicine. Earlier this month, Alnylam got its ATTR drug, Onpattro, approved by the Food and Drug Administration. Shares of Ionis Pharmaceuticals (NASDAQ:IONS) and Akcea Therapeutics (NASDAQ:AKCA), which are jointly developing another ATTR drug, Tegsedi, are up 10% and 2.6% respectively.
Hot Biotech Stocks To Buy Right Now: ArQule Inc.(ARQL)
Advisors' Opinion:- [By Lisa Levin] Gainers Melinta Therapeutics, Inc. (NASDAQ: MLNT) shares surged 20.6 percent to $6.39. WBB Securities upgraded Melinta Therapeutics from Hold to Speculative Buy. Shoe Carnival, Inc. (NASDAQ: SCVL) shares climbed 17.2 percent to $30.87 after the company reported upbeat quarterly earnings. Acorn International, Inc. (NYSE: ATV) shares rose 15.2 percent to $28.804 after the company declared a special one-time cash dividend of $14.97 per ADS. Foot Locker, Inc. (NYSE: FL) gained 15 percent to $53.35 after the company reported better-than-expected results for its first quarter. Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) surged 14.2 percent to $2.625. ArQule, Inc. (NASDAQ: ARQL) rose 13 percent to $5.12 after gaining 4.86 percent on Thursday. Quality Systems, Inc. (NASDAQ: QSII) gained 12.8 percent to $16.97 after the company posted better-than-expected FQ4 results. Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE: LOMA) shares rose 12 percent to $12.94. ArQule, Inc. (NASDAQ: ARQL) shares rose 12 percent to $5.07. Mirati Therapeutics, Inc. (NASDAQ: MRTX) climbed 11.4 percent to $43.50. Zai Lab Limited (NASDAQ: ZLAB) gained 11.3 percent to $24.7000. Zymeworks Inc. (NASDAQ: ZYME) rose 9.7 percent to $19.64. Park City Group, Inc. (NASDAQ: PCYG) climbed 9 percent to $7.90. Roku, Inc. (NASDAQ: ROKU) gained 7.9 percent to $38.82 after Citron reversed previously bearish position on the stock. Sears Holdings Corporation (NASDAQ: SHLD) shares jumped 7.3 percent to $3.55. Deckers Outdoor Corp (NYSE: DECK) rose 3.5 percent to $107.27 after reporting better-than-expected results for its fiscal fourth quarter.
Check out these big penny stock gainers and losers
- [By Joseph Griffin]
Shares of ArQule, Inc. (NASDAQ:ARQL) were down 5.4% during trading on Wednesday . The company traded as low as $4.71 and last traded at $4.73. Approximately 3,358,864 shares traded hands during trading, an increase of 289% from the average daily volume of 863,008 shares. The stock had previously closed at $5.00.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on ArQule (ARQL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Hot Biotech Stocks To Buy Right Now: Biogen Idec Inc(BIIB)
Advisors' Opinion:- [By Keith Speights]
Surprising only begins to describe the latest clinical study results announced by Biogen (NASDAQ:BIIB) and its partner, Japanese drugmaker Eisai (NASDAQOTH:ESALY). On July 5, the two companies reported positive topline results from a phase 2 clinical study of experimental Alzheimer's disease drug BAN2401 at 18 months.
- [By Todd Campbell]
The acquisition of AveXis resulted in an $80 million milestone payment to Regenxbio in Q1 and an additional $100 million payment in June. If AVXS-101 wins an OK, Regenxbio will receive sales royalties in the mid single to low double digits, which could add up to hundreds of millions of dollars annually. For perspective, Biogen's (NASDAQ:BIIB) Spinraza became the only FDA-approved treatment for SMA in late 2016, and its sales are already tracking at an annualized pace of over $1.2 billion, even though only 40% of patients see an improvement on it.
- [By Garrett Baldwin] Nike Inc. (NYSE: NKE) will lead a busy day of earnings reports. The firm expects that its year-over-year sales will have increased by 7%. The company's stock slumped in February after Duke basketball player Zion Williamson was hurt blowing out his sneaker in the first minute of a major contest against North Carolina. Expect analysts to ask a lot of questions about Nike's expectations for global economic growth and its exposure to a weakening Chinese economy. Stocks to Watch Today: BIIB, BA, LEVI Shares of Biogen Inc. (NASDAQ: BIIB) plunged more than 25% after the company announced a major setback for a key Alzheimer's drug. The biotech giant announced that its experimental drug "aducanumab" is unlikely to be effective for mass deployment and that it will halt its research. One analyst described this as a "transformative failure for Biogen's pipeline." This is a massive setback for one of the top biotech companies in the world. Shares of Boeing Co. (NYSE: BA) are off again Thursday on news that the investigation into its 737 Max jets has expanded. According to reports, the FBI has now joined a federal investigation into the certification process for the jet. The Department of Transportation launched an audit of the Federal Aviation Administration's approval of the jet, which received certification two years ago. Boeing and the FAA have faced global scrutiny over two fatal crashes involving the 737 Max jet series and news of previous pilot complaints about the planes. Levi Strauss & Co. (NYSE: LEVI) will return to the public markets for the first time in 34 years. The iconic apparel company will launch its IPO today with a price of $17 per share. That would set the company's market capitalization at $6.6 billion. Look for other earnings reports from Canadian Solar Inc. (NASDAQ: CSIQ), Cintas Corp. (NASDAQ: CTAS), CNOOC Ltd. (NYSE: CEO), Conagra Brands Inc. (NYSE: CAG), Darden Restaurants Inc. (NYSE: DRI), and Lands' End Inc. (NYSE: LE). Public Law 92-
Hot Biotech Stocks To Buy Right Now: Amgen Inc.(AMGN)
Advisors' Opinion:- [By Todd Campbell]
Amgen (NASDAQ:AMGN) may not be as exciting a stock to own as clinical-stage upstarts, but shares in this biotech Goliath have been mounting a rally lately that should make every investor take notice. So far in 2018, Amgen's rewarded investors with an 18% return.
- [By Chris Lange]
Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 10.24 million shares from the previous level of 10.63 million. Shares were last seen trading at $206.00, in a 52-week trading range of $163.31 to $210.19.
- [By Ethan Ryder]
Wayne Hummer Investments L.L.C. trimmed its position in shares of Amgen (NASDAQ:AMGN) by 11.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,311 shares of the medical research company’s stock after selling 303 shares during the period. Wayne Hummer Investments L.L.C.’s holdings in Amgen were worth $394,000 at the end of the most recent quarter.
- [By Chris Lange]
Amgen Inc. (NASDAQ: AMGN) saw its short interest rise to 10.78 million shares from the previous level of 9.98 million. Shares were last seen trading at $196.64, in a 52-week trading range of $163.31 to $201.23.
- [By Chris Lange]
Amgen Inc. (NASDAQ: AMGN) shares made a slight gain on Tuesday after it was announced that the U.S. Food and Drug Administration (FDA) approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture. Specifically, the agency approved Prolia (denosumab), driven by positive late-stage results.
- [By Chris Lange]
Amgen Inc. (NASDAQ: AMGN) saw its short interest fall to 9.98 million shares from the previous level of 10.31 million. Shares were last seen trading at $193.97, in a 52-week trading range of $163.31 to $201.23.
Post to FacebookPosted!
A worker cleans a Tesla Model S sedan before an event to deliver the first set of cars to customers in Beijing, April 22, 2014. Ng Han Guan, APFullscreen
A Tesla Roadster and "Starman" mannequin head toward deep space after launching on Falcon Heavy on Feb. 6, 2018. Tesla via Getty ImagesFullscreen
2 Tesla Model 3's. TeslaFullscreen
AFP/Getty ImagesTesla founder Elon Musk presents the new Roadster electric sports vehicle at Tesla's Los Angeles design centre, Nov. 16, 2017. TESLA HANDOUT, EPA-EFEFullscreen
Some of twelve Tesla Roadsters bound for Japan are seen at a dock in Port Hueneme, Calif. April 21, 2010. Chuck Kirman, APFullscreen
A lot full of Tesla vehicles in Chicago, Dec. 18, 2018. Teresa Crawford, APFullscreen
Guest test-drive the new Tesla Model S P85D after Tesla Motors Inc., announced its new all-wheel-drive version of the Tesla Model S car in Hawthorne, Calif., Oct. 9, 2014. Ringo H.W. Chiu, APFullscreen
Workers assembly a Tesla Roadster at their showroom in Menlo Park, Calif. Sept. 16, 2008. Paul Sakuma, APFullscreen
A Tesla Roadster Sport at a charging station in Portland, Ore. May 27, 2011. Rick Bowmer, APFullscreen
Visitors to the Capitol had the opportunity to inspect the Tesla Motors Model S electric sedan on display in Sacramento, Calif., June 18, 2013. Built in Fremont, the Model S has a seating capacity for five adults and can travel up to 300 miles per charge, depending on which battery package purchased. The starting price for the base Model S is $69,900. Rich Pedroncelli, APFullscreen
"Starman" sitting in SpaceX CEO Elon Musk's cherry red Tesla roadster after a Falcon Heavy rocket delivered it into orbit around the Earth on Feb. 6, 2018. AFP/Getty ImagesFullscreen
A Tesla Model 3 is on display in Los Angeles at Automobility LA, Nov. 29, 2019. FREDERIC J. BROWN, AFP/Getty ImagesFullscreen
Elon Musk, co-founder and chief executive officer of Tesla Inc., arrives in a modified Tesla Model X electric vehicle during an unveiling event for the Boring Co. Hawthorne test tunnel in Hawthorne, Calif., Dec. 18, 2018. Robyn Beck, AFP/Getty ImagesFullscreen
Two people inspect the rear boot of Tesla's latest car "Model 3" during its first exhibition day in Spain, at the Tesla's store in Barcelona Nov. 14, 2018. JOSEP LAGO, AFP/Getty ImagesFullscreen
Elon Musk CEO, Cofounder, Chief Product Architect for Tesla with a new Model S car outside the Tesla customer deliver area at the Tesla Fremont factory, June 21, 2012. Jessica Brandi Lifland, USA TODAYFullscreen
People walk past a Tesla dealership on Jan. 4, 2019 in Berlin, Germany. Tesla is expected to soon begin deliveries of the Model 3 in Europe even though the car has not yet been officially approved by European authorities. Sean Gallup, Getty ImagesFullscreenInterested in this topic? You may also want to view these photo galleries:Replay

Tesla owners love sharing photos of their cars. We invited drivers across social media to send us their favorite shots. Tom Moloughney, who runs a Tesla Model 3 Facebook group with nearly 41,000 members, shared a shot of the car he test drove. He was a first-day reservation holder. Tom MoloughneyFullscreen
Min and Chad Hurin figured out a way to afford to buy their Teslas -- rent them out, airbnb style. Their company, Frunk Yea, has a fleet -- an S, a 3 and an X -- and are based in San Diego and Tampa. Min HurinFullscreen
A Model 3 trickle charging in the North Woods of Minnesota. Bryce PierFullscreen
Along with Models S, 3 and X come a couple of babies. The shot features a 2016 Model S 70D, a 2018 Performance Model 3 and a 2016 Model X 90D with a couple of Radio Flyer Tesla Model S's for the kids. Among the long list of Rema Shalan's favorite things about her Model X are the self-presenting doors, summon feature and Bioweapon Defense Mode. Rema ShalanFullscreen
Christopher Chan says that before the Tesla, "my favorite car was the BMW 328i 2012, which I loved driving until the kids were born." (He had to swap it for the popular parent-mobile, the Honda Odyssey.) While he said he "missed that 'ultimate driving machine' feeling" of the BMW, "the Model 3 is the BMW experience plus more." This was taken Dec. 8, 2018, at Santana Row in San Jose, California. https://www.christopher-chan.com Christopher ChanFullscreen
Karina's Model X sports custom wheels, tinted windows and a satin metallic purple wrap. Karina WuFullscreen
This is "Marvin," a Model S that Kristy Eisele bought in 2016 and drove from New York to California and back to take her son to college. This shot was taken in Reno, Nevada. "[B]eing able to put the car in Autopilot takes away a lot of stress of driving long distances," she says. "At the end of the day, I can arrive at my destination and not be exhausted." Kristy Eisele (@razemfrazem)Fullscreen
Ryan's Model 3 in St. Petersburg, Florida, October 2018. He's had the car since June and says it's his "favorite thing." "The car is constantly evolving and they provide the updated features for free. Not even the iPhone gives you that much with an update without purchasing a new model." He's a big fan of the self-driving capabilities: "I don't know how I drove before without it. I used to dread long drives or driving in traffic, but this makes it so simple and easy." Ryan TickleFullscreen
"Ruby Rose" is Adam Etkin's 2018 long-range, rear wheel drive Tesla Model 3, with chrome delete and custom Aero wheel covers. Adam EtkinFullscreen
Clay Whitely, from Sacramento, says driving his Model 3 "puts a smile on my face every time I sit down in the drivers seat. No car has ever done that before, for me." Clay WhiteleyFullscreen
Rick Teremi says he and his partner, Michelle Leale, were among the first to pre-order in 2016. The car arrived Oct. 1, 2018, in Chicago. "[S]pending $60k for a car sight unseen was quite the plunge." This one's Michelle's. Rick is planning to buy one for himself next month. They will have his-and-hers both in white -- but his will have the white interior. Hers sports the black. Rick TeremiFullscreen
Behold "Purple Reign." Some details about the customization of the Model 3 sporting the white vegan leather interior: The vinyl wrap color is Black Rose Metallic. The 20-inch sport wheels are powder coated in gray metallic. "I've had some nice cars before, Audi, Mercedes, BMW, etc., but there has never been a community amongst the owners like Tesla," says owner Scott Berland. "Sometimes it's members argue (like a family) but it's still a far more communal experience than any of the others." Scott BerlandFullscreen
Rodney Bailey, at the Hudson River in Weehawken, New Jersey, credits his Model 3 "Tess" with making him a better driver "even though I thought I was pretty good prior to ownership." Rodney BaileyFullscreen
Notice the customized red Tesla T on the frunk, or front trunk. "The instant torque and sporty handling really make the Model 3 a fun car to drive," says owner Allen Lau. "The functionality of the touchscreen console and Auto Pilot are just some of the features that really makes driving a pleasant experience in the Model 3." Allen LauFullscreen
Gaurav Mahendru shared his picture of "Pearl," a Tesla Model 3 in Pearl White with 18-inch Aero Wheels, outside the iconic Milwaukee Art Museum. His family got the car last September after waiting 17 months. They were among those who reserved the car before it was in production. "We have already done 5,000 miles on it! We had a 2004 Toyota Camry before this and we were past due for an upgrade....We are so much in love with this car that we are never going back to gas cars ever again." Aside, from the car being electric, its safety record, design and being a tech gadget "built around a computer," he feels a part of something bigger: "The feeling of being a part of a movement!" Gaurav MahendruFullscreen
Kristy Eisele says she loved her Model S experience so much, she bought a Model 3 last November in Deep Blue Metallic with 19-inch Sport wheels and black and white interior. Kristy Eisele (@razemfrazem)Fullscreen
Alyson Vogel's car family includes two Model 3s. The second they bought on New Year's Eve, ahead of the tax credit partially expiring. "We bought it in 4 hours from California, and they delivered it to our garage in N.Y. while we signed the paperwork in California!" Alyson VogelFullscreen
Elaine Borseth, vice president of the Electric Vehicle Association of San Diego, says she's done a couple of San Diego to Maine roundtrips and a 16,000-mile trek that took her all over North America in her P85D. "I've charged my car everywhere from Superchargers to 110 outlets at homes, businesses and hotels, RV parks, a 240 outlet on the side of an unoccupied cabin in the Upper Peninsula of Michigan (all with the owners' permission via plugshare) to my own garage." #CoastToCoastTeslaFullscreenInterested in this topic? You may also want to view these photo galleries:Replay